Indication
Respiratory syncytial virus infection
Respiratory syncytial virus infection is a contagious viral illness of the upper and lower respiratory tracts caused by human respiratory syncytial virus (RSV). Read more about Respiratory syncytial virus infection
3 drugs 3 manufacturers
Drugs that treat it
Common Respiratory syncytial virus infection therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRespiratory syncytial virus infection is a contagious viral illness of the upper and lower respiratory tracts caused by human respiratory syncytial virus (RSV).
While it commonly produces mild, self-limited upper respiratory symptoms in healthy older children and adults, it is a leading cause of severe lower respiratory tract disease—notably bronchiolitis and pneumonia—in infants, young children, older adults, and immunocompromised individuals.
Pathophysiologically, viral replication in the respiratory epithelium triggers robust mucosal inflammation, ciliary dysfunction, epithelial cell necrosis, and increased mucus production.
This cascade leads to small-airway obstruction, ventilation-perfusion mismatch, and defining clinical features such as rhinorrhea, persistent cough, tachypnea, wheezing, and varying degrees of respiratory distress.
- nih.gov
Respiratory syncytial virus infection is a contagious viral illness of the upper and lower respiratory tracts caused by human respiratory syncytial virus (RSV)
- nih.gov
Respiratory syncytial virus infection is a contagious viral illness of the upper and lower respiratory tracts caused by human respiratory syncytial virus (RSV) While it commonly produces mild, self-limited upper respiratory symptoms in healthy older children and adults, it is a leading cause of severe lower respiratory tract disease—notably bronchiolitis and pneumonia—in infants, young children, older adults, and immunocompromised individuals Pathophysiologically, viral replication in the respir...
- cdc.gov
While it commonly produces mild, self-limited upper respiratory symptoms in healthy older children and adults, it is a leading cause of severe lower respiratory tract disease—notably bronchiolitis and pneumonia—in infants, young children, older adults, and immunocompromised individuals
- nih.gov
While it commonly produces mild, self-limited upper respiratory symptoms in healthy older children and adults, it is a leading cause of severe lower respiratory tract disease—notably bronchiolitis and pneumonia—in infants, young children, older adults, and immunocompromised individuals
- nih.gov
Pathophysiologically, viral replication in the respiratory epithelium triggers robust mucosal inflammation, ciliary dysfunction, epithelial cell necrosis, and increased mucus production This cascade leads to small-airway obstruction, ventilation-perfusion mismatch, and defining clinical features such as rhinorrhea, persistent cough, tachypnea, wheezing, and varying degrees of respiratory distress
- cdc.gov
This cascade leads to small-airway obstruction, ventilation-perfusion mismatch, and defining clinical features such as rhinorrhea, persistent cough, tachypnea, wheezing, and varying degrees of respiratory distress
Personalize your experience
Follow Respiratory syncytial virus infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.